ELISA Kit for Cytochrome C Oxidase Subunit II (COX2)
SED284RA
Product group Assays
Overview
- SupplierCloud-Clone Corp.
- Product NameELISA Kit for Cytochrome C Oxidase Subunit II (COX2)
- Delivery Days Customer9
- Assay Detection Range0.312-20ng/mL
- Assay PrecisionIntra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Cytochrome C Oxidase Subunit II (COX2) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with ...
- Assay SensitivityThe minimum detectable dose of this kit is typically less than 0.124ng/mL
- Assay SpecificityThis assay has high sensitivity and excellent specificity for detection of Cytochrome C Oxidase Subunit II (COX2). No significant cross-reactivity or interference between Cytochrome C Oxidase Subunit II (COX2) and analogues was observed.
- Assay Test PrincipleThe test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Cytochrome C Oxidase Subunit II (COX2). Standards or samples are then added to the ...
- Assay Time3h
- CertificationResearch Use Only
- UNSPSC41116158
References
- Quercetin-3-methyl ether inhibits esophageal carcinogenesis by targeting the AKT/mTOR/p70S6K and MAPK pathways. Zhao S et al., 2018 Nov, Mol CarcinogRead more
- Celecoxib Prevents Cognitive Impairment and Neuroinflammation in Soluble Amyloid beta-treated Rats. Mhillaj E et al., 2018 Feb 21, NeuroscienceRead more
- Effect of single and repeated heat stress on chemical signals of heat shock response cascade in the rats heart. Ilievska G et al., 2018 Jul, Cell Stress ChaperonesRead more
- Soy isoflavone genistein attenuates lipopolysaccharide-induced cognitive impairments in the rat via exerting anti-oxidative and anti-inflammatory effects. Mirahmadi SM et al., 2018 Apr, CytokineRead more
- Docking Studies and Biological Evaluation of a Potential beta-Secretase Inhibitor of 3-Hydroxyhericenone F from Hericium erinaceus. Diling C et al., 2017, Front PharmacolRead more